perampanel + perampanel
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Partial Onset Epilepsy
Conditions
Partial Onset Epilepsy
Trial Timeline
Jun 1, 2010 → Sep 1, 2010
NCT ID
NCT01240187About perampanel + perampanel
perampanel + perampanel is a phase 1 stage product being developed by Eisai for Partial Onset Epilepsy. The current trial status is completed. This product is registered under clinical trial identifier NCT01240187. Target conditions include Partial Onset Epilepsy.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (8)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04202159 | Pre-clinical | Completed |
| NCT03754582 | Phase 2 | Completed |
| NCT03399734 | Phase 1 | Completed |
| NCT03376997 | Phase 1 | Completed |
| NCT02020486 | Phase 1 | Completed |
| NCT01396577 | Phase 1 | Completed |
| NCT01396590 | Phase 1 | Completed |
| NCT01240187 | Phase 1 | Completed |
Competing Products
20 competing products in Partial Onset Epilepsy
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| E2007 | Eisai | Phase 3 | 77 |
| Perampanel | Eisai | Pre-clinical | 23 |
| perampanel + perampanel + perampanel + Placebo | Eisai | Phase 3 | 77 |
| Perampanel + Placebo | Eisai | Approved | 85 |
| Perampanel and Microgynon-30 + Perampanel and Microgynon-30 | Eisai | Phase 1 | 33 |
| perampanel | Eisai | Phase 2 | 52 |
| Perampanel | Eisai | Pre-clinical | 23 |
| Zonisamide + Placebo | Eisai | Phase 3 | 77 |
| zonisamide | Eisai | Pre-clinical | 23 |
| E2007 (perampanel) + E2007 (perampanel) + Placebo | Eisai | Phase 3 | 77 |
| Perampanel + Placebo | Eisai | Phase 3 | 77 |
| E2007 (perampanel) + E2007 (perampanel) + Placebo | Eisai | Phase 3 | 77 |
| Adjunctive Zonisamide + Replacement with Zonisamide | Eisai | Approved | 85 |
| Fycompa | Eisai | Pre-clinical | 23 |
| Zonisamide + Placebo | Eisai | Phase 3 | 77 |
| Fycompa | Eisai | Pre-clinical | 23 |
| Rufinamide | Eisai | Phase 3 | 77 |
| Zonisamide | Eisai | Phase 3 | 77 |
| Eslicarbazepine Acetate tablets | Eisai | Pre-clinical | 23 |
| Perampanel | Eisai | Pre-clinical | 23 |